Brokerages Set Avantor, Inc. (NYSE:AVTR) PT at $10.62

Shares of Avantor, Inc. (NYSE:AVTR) have earned an average recommendation of “Hold” from the eighteen ratings firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $12.00.

A number of analysts have commented on the stock. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a report on Wednesday, July 15th. Barclays boosted their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, June 24th. Citigroup raised their target price on Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Finally, Morgan Stanley boosted their price target on Avantor from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Thursday.

Trending Headlines about Avantor

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Q2 earnings and revenue beat expectations. Avantor reported adjusted EPS of $0.21 versus the $0.19 consensus estimate and revenue of $1.692 billion versus expectations of $1.61 billion. Adjusted EBITDA was $254.3 million, operating cash flow was $178.2 million and free cash flow was $142.8 million. Avantor Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised full-year 2026 guidance. Avantor now expects adjusted EPS of $0.80-$0.83, above the prior consensus estimate of $0.79, and increased its organic revenue outlook. The company also continues targeting adjusted net leverage below 3x, supporting the deleveraging narrative. Avantor 2026 Guidance
• Positive Sentiment: VWR showed signs of recovery. The VWR segment returned to organic growth earlier than expected, while segment execution and strategic initiatives helped support the guidance increase. The earnings beat initially drove a gap higher in AVTR shares.
• Positive Sentiment: Several analysts lifted price targets. Wells Fargo raised its target to $16 and maintained an overweight rating, while Stifel increased its target to $15 and Morgan Stanley raised its target to $14, although both retained neutral ratings.
• Neutral Sentiment: Growth remains modest. Second-quarter sales increased just 0.5% year over year, while organic revenue declined 0.4%, indicating that the recovery is still uneven.
• Negative Sentiment: Profitability comparisons weakened. Adjusted EPS declined from $0.24 a year earlier, and Avantor reported a $0.06 GAAP EPS result alongside a negative net margin. Jefferies upgraded the stock only to hold with a $13 target, suggesting limited upside after the recent rally.

Avantor Trading Down 3.9%

Avantor stock opened at $13.82 on Friday. The business has a 50-day simple moving average of $10.14 and a two-hundred day simple moving average of $9.42. The company has a market cap of $9.44 billion, a P/E ratio of -16.45, a P/E/G ratio of 7.88 and a beta of 0.94. Avantor has a 52-week low of $7.26 and a 52-week high of $15.93. The company has a quick ratio of 1.17, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.02. The firm had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts predict that Avantor will post 0.8 EPS for the current year.

Insider Buying and Selling at Avantor

In related news, Director Gregory T. Lucier acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was bought at an average cost of $8.32 per share, for a total transaction of $83,200.00. Following the purchase, the director owned 60,000 shares in the company, valued at $499,200. The trade was a 20.00% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.28% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Avantor

Large investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its position in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the period. Private Trust Co. NA raised its position in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares during the period. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor during the 2nd quarter valued at $32,000. Los Angeles Capital Management LLC purchased a new position in shares of Avantor during the 4th quarter valued at $32,000. Finally, Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.